Prof. Szekely Laszlo

Prof. Szekely Laszlo

MD. PhD. Professor of Hematological Malignancies

Department of Microbiology, Tumor and Cellbiology (MTC), Karolinska Institutet
Nobelsväg 16, Stockholm, Sweden, 17177

plus Speciality

ONCOLOGY

Biography:

Laszlo Szekely gained his degree in medicine in 1988 from Debrecen's medical university. That same year he was awarded the Weszpremi medal as the best medical student at the university. He moved to Sweden in 1988 and to a research post with Prof. George Klein at the former department of tumour biology at the Karolinska Institute. 1989-1995 worked on the molecular biology of tumor suppressor proteins Rb and p53 with special reference of their involment in cell differentiation and gamma herpes virus mediated B cell transformation. In 1993 he moved over to a research position at MTC. He gained his PhD in 1995 at Karolinska Institutet. Between 1996 and 1997 he did his postdoc financed by the Swedish Cancer Society, and then another post as a cancer researcher from 1997 to 2003. In 2000 he became an associate professor at Karolinska Institutet. Between 2003 and 2009 he was employed as a project leader at the Center for Integrative Recognition in the Immune System (IRIS), and he also had a research post at SSF Center of Excellence at the Royal Institute of Technology. Since this year he has also worked as a technical consultant at the Karolinska Visualization Core Facility (KIVIF). In 2010 he became a senior lecturer at Karolinska Institutet. Laszlo Szekely was appointed professor of haematological malignant diseases at Karolinska Institutet in 2010. He has over 90 publications of which 86 were cited 3133 times by 2013-03-01. Average Citations per Article: 36.43, h-index: 30

Academic positions:

1996 - 1997 postdoctoral fellow ( Swedish Cancer Society ) 1997– 2003 cancer researcher ( Swedish Cancer Society ) 2000-03-21 associate professor at the Karolinska Institute 2003 – 2009 project leader – research scientist at the SSF Center of Excellence – Center for Integrative Recognition in the Immune System (IRIS) (director: Prof. Klas Kärre) since 2003 Senior technical consultant at the Karolinska Visualization Core Facility (KIVIF) 2004 –2009 senior researcher (Swedish Research Council ) 2010.01.01 – appointed as senior lecturer (Karolinska Institutet) 2010.12.01 - appointed as professor of hematopoetic malignancies at MTC, Karolinska Institutet

Research interests:

Research interests include the development of individualized cancer therapy based on ex vivo drug sensitivity assays. Creator of iVV and SolidSense assays, developed the OFB general purpose fluorescent staining. High throughput automated imaging based assay development. Hardware and software development. Image analysis and machine vision. Development of HexaScope, extended field laser confocal microscopy, extended depth of field imaging. Automated analysis of mammography images.

What I think of the idea behind WebmedCentral and WebmedCentral plus:

Excellent idea. Good science requires uninhibited flow of information, unrestricted access to the latest results and ideas. At the age of the web based social medias the traditional publication systems appear to be more and more outdated. The quality of the research should be measured by the reproducibility of the results and not by the percieved prestige of the journal where the data are published. Reader feedback is more important than pre-publication peer review with its many flaws (e.g. see comments at J. of Biology 2009, 8:24) New type of research constellations, new mixtures of interdisciplinary collaborative efforts and the ever increasing role of in silico analysis of publicly available data also requires a new and flexible formats of publishing.